CVE-2026-18740

CVE-2026-18740 is a high-severity vulnerability in Ibm Security Verify Access with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-88.

Key facts

Description

IBM Security Verify Access 10.0 through 10.0.9.2 and IBM Verify Identity Access 11.0 through 11.0.3 could allow a remote authenticated attacker to perform unauthorized actions due to argument injection.

Frequently asked questions

What is CVE-2026-18740?
IBM Security Verify Access 10.0 through 10.0.9.2 and IBM Verify Identity Access 11.0 through 11.0.3 could allow a remote authenticated attacker to perform unauthorized actions due to argument injection.
How severe is CVE-2026-18740?
CVE-2026-18740 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-18740 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-18740?
CVE-2026-18740 primarily affects Ibm Security Verify Access. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-18740?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-18740 published?
CVE-2026-18740 was published on 2026-10-08 and last updated on 2026-10-10.

References

Affected products (4)

More vulnerabilities in Ibm Security Verify Access

All CVEs affecting Ibm Security Verify Access →

Other CWE-88 (Argument Injection) vulnerabilities

Browse all CWE-88 (Argument Injection) vulnerabilities →